Encompass Health
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
CHARBONNEAU ELISSA JOY officer: Chief Medical Officer
Encompass Health Common Stock 10,000 $85.02 $850,200
Option
DARBY JOHN PATRICK officer: EVP, Gen Counsel & Sec..
Encompass Health Common Stock 14,543 $29.06 $422,620
Sale
DARBY JOHN PATRICK officer: EVP, Gen Counsel & Sec..
Encompass Health Common Stock 14,543 $83.94 $1,220,739
Option
DARBY JOHN PATRICK officer: EVP, Gen Counsel & Sec..
Non-qualified Stock Option (Right to Buy) 14,543 $29.06 $422,620
Purchase
CARMICHAEL GREG D director
Encompass Health Common Stock 2,000 $83.73 $167,460
Option
TARR MARK J director, officer: President & ..
Encompass Health Common Stock 25,516 $29.06 $741,495
Option
TARR MARK J director, officer: President & ..
Encompass Health Common Stock 19,460 $35.83 $697,252
Sale
TARR MARK J director, officer: President & ..
Encompass Health Common Stock 44,976 $83.27 $3,745,152
Option
TARR MARK J director, officer: President & ..
Non-qualified Stock Option (Right to Buy) 44,976 $32.45 $1,459,246
Option
COLTHARP DOUGLAS E officer: EVP & Chief Financial ..
Encompass Health Common Stock 16,623 $26.55 $441,341
Sale
COLTHARP DOUGLAS E officer: EVP & Chief Financial ..
Encompass Health Common Stock 11,215 $63.39 $710,919
Option
COLTHARP DOUGLAS E officer: EVP & Chief Financial ..
Non-qualified Stock Option (Right to Buy) 16,623 $26.55 $441,341
Sale
CHARBONNEAU ELISSA JOY officer: Chief Medical Officer
Encompass Health Common Stock 8,294 $69.58 $577,097
Option
TARR MARK J director, officer: President & ..
Encompass Health Common Stock 25,330 $26.55 $672,512
Sale
TARR MARK J director, officer: President & ..
Encompass Health Common Stock 25,330 $71.06 $1,799,950
Option
TARR MARK J director, officer: President & ..
Non-qualified Stock Option (Right to Buy) 25,330 $26.55 $672,512
Option
COLTHARP DOUGLAS E officer: EVP & Chief Financial ..
Non-qualified Stock Option (Right to Buy) 17,895 $20.07 $359,153
Sale
COLTHARP DOUGLAS E officer: EVP & Chief Financial ..
Encompass Health Common Stock 17,895 $60.78 $1,087,658
Option
COLTHARP DOUGLAS E officer: EVP & Chief Financial ..
Encompass Health Common Stock 17,895 $20.07 $359,153
Purchase
CARMICHAEL GREG D director
Encompass Health Common Stock 1,830 $54.67 $100,046
Option
TARR MARK J director, officer: President & ..
Non-qualified Stock Option (Right to Buy) 20,449 $20.07 $410,411
Sale
TARR MARK J director, officer: President & ..
Encompass Health Common Stock 20,449 $53.25 $1,088,909
Option
TARR MARK J director, officer: President & ..
Encompass Health Common Stock 20,449 $20.07 $410,411
Purchase
O'CONNOR KEVIN J. director
Encompass Health Common Stock 1,000 $66.48 $66,480
Option
COLTHARP DOUGLAS E officer: EVP & Chief Financial ..
Non-qualified Stock Option (Right to Buy) 26,132 $21.02 $549,295
Option
COLTHARP DOUGLAS E officer: EVP & Chief Financial ..
Encompass Health Common Stock 26,132 $21.02 $549,295
Purchase
WILLIAMS TERRANCE director
Encompass Health Common Stock 354 $56.61 $20,040
Option
ANTHONY APRIL KAYE BULLOCK officer: CEO & President, Home ..
Encompass Health Common Stock 7,583 $70.16 $531,985
Option
ANTHONY APRIL KAYE BULLOCK officer: CEO & President, Home ..
Non-qualified Stock Option (Right to Buy) 7,583 $70.16 $531,985
Sale
PRICE ANDREW L officer: Chief Accounting Officer
Encompass Health Common Stock 8,589 N/A N/A
Sale
CHARBONNEAU ELISSA JOY officer: Chief Medical Officer
Encompass Health Common Stock 6,650 $75.22 $500,213
Sale
COLTHARP DOUGLAS E officer: EVP & Chief Financial ..
Encompass Health Common Stock 23,501 $75.94 $1,784,666
Option
COLTHARP DOUGLAS E officer: EVP & Chief Financial ..
Encompass Health Common Stock 23,501 $24.21 $568,959
Option
COLTHARP DOUGLAS E officer: EVP & Chief Financial ..
Non-qualified Stock Option (Right to Buy) 23,501 $24.21 $568,959
Sale
JACOBSMEYER BARBARA ANN officer: President, Inpatient H..
Encompass Health Common Stock 2,500 $64.73 $161,825
Option
TARR MARK J director, officer: President & ..
Non-qualified Stock Option (Right to Buy) 26,132 $21.02 $549,295
Option
TARR MARK J director, officer: President & ..
Encompass Health Common Stock 26,132 $21.02 $549,295
Sale
TARR MARK J director, officer: President & ..
Encompass Health Common Stock 26,132 $21.02 $549,295
Purchase
ANTHONY APRIL KAYE BULLOCK officer: CEO & President, Home ..
Encompass Health Common Stock 125,000 $57.99 $7,248,875
Sale
CORRELL DONALD L director
Encompass Health Common Stock 2,000 $59.04 $118,080
Purchase
ANTHONY APRIL KAYE BULLOCK officer: CEO & President, Home ..
Encompass Health Common Stock 40,000 $64.24 $2,569,600
Purchase
HIGDON LEO I JR director
Encompass Health Common Stock 1,000 $64.07 $64,070
Purchase
CURL YVONNE M director
Encompass Health Common Stock 500 $69.19 $34,595
Option
TARR MARK J director, officer: President & ..
Encompass Health Common Stock 67,382 $18.82 $1,268,129
Option
TARR MARK J director, officer: President & ..
Non-qualified Stock Option (Right to Buy) 10,550 $14.95 $157,723
Sale
TARR MARK J director, officer: President & ..
Encompass Health Common Stock 67,382 $63.49 $4,277,746
Purchase
HIGDON LEO I JR director
Encompass Health Common Stock 1,000 $58.84 $58,840
Sale
PRICE ANDREW L officer: Chief Accounting Officer
Encompass Health Common Stock 9,457 $80.04 $756,938
Sale
LEVY CHERYL B. officer: Chief Human Resources ..
Encompass Health Common Stock 28,955 $78 $2,258,490
Sale
JACOBSMEYER BARBARA ANN officer: President, Inpatient H..
Encompass Health Common Stock 1,798 $62.73 $112,789

Showing 1 to 50 of 165 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.